Abstract
Inflammatory bowel disease (IBD), which consists of Crohn’s disease and ulcerative colitis, is defined as a chronic inflammation of the gastrointestinbal tract. The etiopathogenetic mechanisms underlying the development of IBD are still not completely understood, and the therapeutic strategies used thus far have been limited to mostly evidence-based principles. There is growing evidence that the pro-inflammatory cytokine interleukin (IL)-6 plays a crucial part in the uncontrolled intestinal inflammatory process, which is a main characteristic of IBD. There is elevated production of IL-6 and its soluble receptor (sIL-6R) by intestinal macrophages and CD4+ T-cells. The increased formation of IL-6-sIL-6R complexes that interact with gp130 on the membrane of CD4+ T-cells (trans-signaling) lead to an increased expression and nuclear translocation of STAT3, which causes the induction of anti-apoptotic genes, such as Bcl-xl. This leads to an augmented resistance of lamina propria T-cells to apoptosis. The ensuing T-cell expansion contributes to the perpetuation of chronic intestinal inflammation. This understanding concerning the predominant pathogenic role of an IL-6-dependent inflammatory cascade may lead to the development of new therapeutic strategies in the treatment of this disease. Recent studies have also suggested a potential role of IL-6-sIL-6R in the pathogenesis of colon cancer and, therefore, imply a possible novel therapeutic strategy targeting the sIL-6R and ensuing IL-6 trans-signaling.
Article PDF
Similar content being viewed by others
References
Podolsky, D. K. (1991), N. Engl. J. Med. 325, 928–937.
Duchmann, R. and Zeitz, M. (1999), In: Mucosal Immunology, 2nd ed., Ogra, P. L., Mestecky, J., Lamm, M., Strober, W., Bienenstock, J., and McGhee, J.R., eds., San Diego: Academic Press, pp. 1055–1080
Karp, L. C. and Targan, S. R. (1999), In: Mucosal Immunology, 2nd ed., Ogra, P. L., Mestecky, J., Lamm, M., Strober, W., Bienenstock, J., and McGhee, J. R., eds., San Diego: Academic Press, pp. 1047–1053.
Shanahan, F. (2001), Lancet 359, 62–69.
Eaden, J.A., Abrams, K., and Mayberry, J.F. (2001), Gut 48, 526–535.
Ekbom, A., Helmick, C., Zack, M., and Adami, H. O. (1990), N. Engl. J. Med. 323, 1228–1233.
Munkholm P., Langholz W., Davidsen M., and Binder V. (1993), Gastroenterology 105, 1716–1723.
Podolsky, D. K. (2002), N. Engl. J. Med. 347, 417–429.
Fiocchi, C. (1998), Gastroenterology 115, 182–205.
Neurath, M. F., Finotto, S., and Glimcher, L. H. (2002), Nat. Med. 8, 567–573.
Sartor, R. B. (1994), Gastroenterology 106, 533–539.
Rutgeerts, P., van Deventer, S., and Schreiber, S. (2003), Aliment Pharmacol. Ther. 17, 1435–1450.
Ina, K., Binion, D. G., West, G. A., Dobrea, G. M., and Fiocchi, C. (1995), Gastroenterology 108, A841.
Neurath, M. F. and Mayer zum Büschenfelde, K. H. (1996), J. Invest. Med. 44, 516–521.
Fuss, I. J., Neurath, M., Boirivant, M., et al. (1996), J. Immunol. 157, 1261–1270.
Neurath, M. F, Fuss, I., Kelsall B. L., Sttöer, E., and Strober, W. (1995), J. Exper. Med. 182, 1281–1290.
Monteleone, G., Biancone, L., Marasco, R., et al. (1997), Gastroenterology 112, 1169–1178.
Reinecker, H. C., Steffen, M., Witthfot, T., et al. (1993), Clin. Exp. Immunol. 94, 174–181.
Capello, M., Keshav, S., Prince, C., Jewell, D. P., and Gordon, S. (1992), Gut 33, 1214–1219.
Mayer, L. (2000), In: Inflammatory Bowel Disease, 5th ed., Kirsner, J. B. ed., Philadelphia: W. B. Saunders Company, pp. 280–296.
Holub, M. C., Mako, E., Devay, T., et al. (1998), Scand. J. Gastroenterol. Suppl. 228, 47–50.
Hyams, J. S., Fitzgerald, J. E., Treem, W. R., Wyzga, N., and Kreutzer, D. L. (1993), Gastroenterology 104, 1285–1292.
Gross, V., Andus, T., Gösar, I., Roth, M., and Schölmerich, J. (1992), Gastroenterology 102, 514–519.
Mahida, Y. R., Kurlac, L., Gallagher, A., and Hawkey, C. J. (1991), Gut 32, 1531–1534.
Reinisch, W., Gasche, C., Tillinger, W., et al. (1999), Am. J. Gastroenterol. 94, 2156–2164.
Van Kemseke, C., Belaiche, J., and Louis, E. (2000), Int. J. Colorectal Dis. 15, 206–210.
Louis, E., Belaiche, J., van Kemseke, C., et al. (1997), Eur. J. Gastroenterol. Hepatol. 9, 939–944.
Ishiguro, Y. (1999), J. Gastroenterol. 34, 66–74.
Atreya, R., Mudter, J., Finotto, S., et al. (2000), Nat. Med. 6, 583–588.
McCormack, G., Moriarty, D., O’Donoghue, D. P., McCormick, P. A., Sheahan, K., and Baird, A. W. (2001), Inflammation Res. 50, 491–495.
Isaacs, K. L., Sartor R. B., and Haskill, S. (1992), Gastroenterology 103, 1587–1595.
Daig, R., Rogler, G., Aschenbrenner, E., et al. (2000), Gut 46, 350–358.
Reinecker, H. C., Steffen, M., Witthfot, T., et al. (1993), Clin. Exper. Immunol. 94, 174–181.
Kusugami, K., Fukatsu, A., Tanimoto, M., et al. (1995), Digest. Dis. Sciences 40, 949–959.
Taga, T., Hibi, M., Hirata, Y., et al. (1989), Cell 58, 573–581.
Mazlam, M. Z., and Hodgson, H. J. (1994), Gut 35, 77–83.
Autschbach, F., Schrömann, G., Qiao, L., Merz, H., Wallich, R., and Meuer, S. C. (1995), Virchows Arch. 426, 51–60.
Jones, S. C., Crabtree, J. E., Rembacken, B. J., et al. (1994), Scand. J. Gastroenterol. 29, 722–728.
Desreumaux, P., Brandt, E., Gambiez, L., et al. (1997), Gastroenterology 113, 118–126.
Brown, K. A., Back, S. J., Ruchelli, E. D., et al. (2002), Am. J. Gastroenterol. 97, 2603–2608.
Rose-John, S., and Heinrich, P. C. (1994), Biochem. J. 300, 281–290.
Mitsuyama, K., Toyonaga, A., Sasaki, E., et al. (1995), Gut 36, 45–49.
Hosokawa, T., Kusugami, K., Ina, K., et al. (1999), J. Gastroenterol. Hepatol. 14, 987–996.
Kopf, M., Baumann, H., Freer, G., et al. (1994), Nature 3681, 339–342.
Jones, S. A., Novick, D., Horiuchi, S., Yamamoto, N., Szalai, A. J., and Fuller, G. M. (1999), J. Exper. Med. 189, 599–604.
Mackiewicz, A., Schooltink, H., Heinrich, P. C., and Rose-John, S. (1992), J. Immunol. 149, 2021–2027.
Walev, I., Vollmer, P., Palmer, M., Bhakdi, S., and Rose-John, S. (1996), Proc. Natl. Acad. Sciences USA. 93, 7882–7887.
Vollmer, P., Walev, I., Rose-John, S., and Bhakdi, S. (1996), Infect. Immun. 64, 3646–3651.
Wyatt, J., Vogelsang, H., Hbil, W., Waldhoer, T., and Lochs, H. (1993), Lancet 341, 1437–1439.
De Jong, Y. P., Abadia-Molina, A. C., Satoskar, A. R., et al. (2001), Nat. Immunol. 2, 1061–1066.
Boirivant, M., Marini, M., Di Felice, G., et al. (1999), Gastroenterology 116, 557–565.
Ina, K., Itoh, J., Fukushima, K., et al. (1999), J. Immunol. 163, 1081–1090.
Itoh, J., de La Motte, C., Strong, S. A., Levine, A. D., and Fiocchi, C. (2001), Gut 49, 35–41.
Iimura, M., Nakamura, T., Shinozaki, S., et al. (2000), Gut 47, 228–235.
Yamamoto, M., Yoshizaki, K., Kishimoto, T., and Ito, H. (2000), J. Immunol. 164, 4878–4882.
Ito, H., Takazoe, M., Fukuda, Y., et al. (2004), Gastroenterology 126, 989–996.
Van den Brande, J. M. H., Braat, H., van den Brink, G. R., et al. (2003), Gastroenterology 124, 1774–1785.
Weir, H. K., Thun, M. J., Hankey, B. F., et al. (2003), J. Natl. Cancer Inst. 5, 1276–1299.
Chung, Y. C. and Chang, Y. F. (2003), J. Surg. Oncol. 83, 222–226.
Galizia, G., Orditura, M., Romano, C., et al. (2002), J. Clin. Immunol. 102, 169–178.
Schneider, M. R., Hoeflich, A., Fischer, J. R., Wolf, E., Sordat, B., and Lahm, H. (2000), Cancer Lett. 151, 31–38.
Becker, C., Fantini, M. C., Schramm, C., et al. (2004), Immunity 21, 491–501.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Atreya, R., Neurath, M.F. Involvement of IL-6 in the pathogenesis of inflammatory bowel disease and colon cancer. Clinic Rev Allerg Immunol 28, 187–195 (2005). https://doi.org/10.1385/CRIAI:28:3:187
Issue Date:
DOI: https://doi.org/10.1385/CRIAI:28:3:187